|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 25.92 USD | +1.69% |
|
-0.31% | -2.96% |
| Market Cap | 4.44B 3.88B 3.58B 3.29B 6.24B 427B 6.34B 42.74B 16.77B 209B 16.67B 16.3B 719B | P/E 2026 * |
67.4x | P/E 2027 * | 35.2x |
|---|---|---|---|---|---|
| Enterprise Value | 3.47B 3.04B 2.8B 2.58B 4.88B 334B 4.96B 33.45B 13.12B 163B 13.05B 12.76B 563B | EV / Sales 2026 * |
2.8x | EV / Sales 2027 * | 2.34x |
| Free-Float |
99.68% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: ACADIA Pharmaceuticals Inc.
| 1 day | +1.69% | ||
| 1 week | -0.31% | ||
| Current month | +2.45% | ||
| 1 month | +21.89% | ||
| 3 months | +19.12% | ||
| 6 months | -2.30% | ||
| Current year | -2.96% |
| 1 week | 24.95 |  | 26.51 |
| 1 month | 20.92 | | 27.31 |
| Current year | 19.89 | | 27.81 |
| 1 year | 19.69 | | 28.35 |
| 3 years | 13.4 | | 33.99 |
| 5 years | 12.24 | | 33.99 |
| 10 years | 12.24 | | 58.72 |
| Manager | Title | Age | Since |
|---|---|---|---|
Catherine Adams
CEO | Chief Executive Officer | 55 | 20/09/2024 |
Mark Schneyer
DFI | Director of Finance/CFO | 52 | 10/09/2021 |
Scott Cenci
CTO | Chief Tech/Sci/R&D Officer | - | 04/08/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Laura Brege
BRD | Director/Board Member | 68 | 01/05/2008 |
Stephen Biggar
CHM | Chairman | 55 | 10/06/2016 |
Edmund Harrigan
BRD | Director/Board Member | 73 | 25/11/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-26 | Sell | Controller/Auditor | -11,421 | 0.0067% | ||
| 05-29 | Fiscal year | Director | 41,529 | 0.0243% | ||
| 05-29 | Fiscal year | Director | 29,335 | 0.0171% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.69% | -0.31% | +17.76% | -19.45% | 4.44B | |
| -1.44% | -1.72% | +0.49% | +5.80% | 50.35B | |
| -0.29% | -2.81% | +387.81% | +591.82% | 39.21B | |
| -0.49% | +1.48% | +31.16% | -6.46% | 34.52B | |
| +1.53% | +3.11% | +15.41% | +58.54% | 34.6B | |
| +1.68% | -0.62% | +3.30% | +27.34% | 27.05B | |
| +1.13% | -3.11% | - | - | 16.68B | |
| -1.29% | -0.52% | +69.24% | +117.60% | 15.11B | |
| -0.43% | +0.26% | +14.09% | +17.43% | 13.85B | |
| +2.45% | +3.99% | +18.20% | -30.12% | 13.18B | |
| Average | +0.37% | +0.81% | +61.94% | +84.72% | 24.9B | |
| Weighted average by Cap. | -0.00% | +0.81% | +79.59% | +118.70% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.24B 1.08B 1B 920M 1.74B 119B 1.77B 11.95B 4.69B 58.36B 4.66B 4.56B 201B | 1.4B 1.22B 1.13B 1.03B 1.96B 134B 1.99B 13.43B 5.27B 65.62B 5.24B 5.12B 226B |
| Net income | 65.75M 57.49M 53.03M 48.75M 92.37M 6.33B 93.95M 633M 248M 3.09B 247M 242M 10.66B | 134M 117M 108M 99.16M 188M 12.87B 191M 1.29B 505M 6.29B 502M 491M 21.68B |
| Net Debt | -965M -843M -778M -715M -1.35B -92.81B -1.38B -9.29B -3.64B -45.36B -3.62B -3.54B -156B | -1.18B -1.03B -949M -873M -1.65B -113B -1.68B -11.33B -4.45B -55.36B -4.42B -4.32B -191B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/07/26 | $25.92 | +1.69% | 1,274,099 |
| 14/07/26 | $25.49 | -0.04% | 1,221,006 |
| 13/07/26 | $25.50 | -2.75% | 1,562,833 |
| 10/07/26 | $26.22 | -0.72% | 1,442,787 |
| 09/07/26 | $26.41 | +1.58% | 1,801,279 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ACAD Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
